Carroll Financial Associates’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-14
| Closed | – | – | 1340 |
|
|
2017
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 1315 |
|
|
2017
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 1286 |
|
|
2017
Q1 | $0 | Sell |
14
-13
| -48% | -$321 | ﹤0.01% | 1275 |
|
|
2016
Q4 | $0 | Hold |
27
| – | – | ﹤0.01% | 1260 |
|
|
2016
Q3 | $0 | Hold |
27
| – | – | ﹤0.01% | 1266 |
|
|
2016
Q2 | $0 | Hold |
27
| – | – | ﹤0.01% | 1262 |
|
|
2016
Q1 | $0 | Hold |
27
| – | – | ﹤0.01% | 1266 |
|
|
2015
Q4 | $0 | Hold |
27
| – | – | ﹤0.01% | 1199 |
|
|
2015
Q3 | $0 | Buy |
27
+14
| +108% | +$470 | ﹤0.01% | 1213 |
|
|
2015
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1160 |
|
|
2015
Q1 | $0 | Sell |
13
-14
| -52% | -$348 | ﹤0.01% | 889 |
|
|
2014
Q4 | $1K | Hold |
27
| – | – | ﹤0.01% | 714 |
|
|
2014
Q3 | $0 | Hold |
27
| – | – | ﹤0.01% | 995 |
|
|
2014
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 890 |
|
|
2014
Q1 | $1K | Buy |
27
+14
| +108% | +$344 | ﹤0.01% | 840 |
|
|
2013
Q4 | $0 | Sell |
13
-14
| -52% | -$254 | ﹤0.01% | 929 |
|
|
2013
Q3 | $0 | Buy |
+27
| New | +$364 | ﹤0.01% | 882 |
|
Carroll Financial Associates's PMC Position: Q4 2017 in Review
Carroll Financial Associates sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 14 shares.
Carroll Financial Associates first reported a position in PMC in Q3 2013 and held it in 17 quarters. The position peaked at $1K in Q4 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Carroll Financial Associates reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Carroll Financial Associates sold 14 PharMerica Corporation shares in Q4 2017.
- Carroll Financial Associates first reported a position in PharMerica Corporation in Q3 2013 and held it in 17 quarters.
- Carroll Financial Associates's PharMerica Corporation position peaked at $1K in Q4 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Carroll Financial Associates's 13F filing for Q4 2017, filed 18 Jan 2018.